Pages that link to "Q28475537"
Jump to navigation
Jump to search
The following pages link to Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model (Q28475537):
Displayed 21 items.
- Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group (Q27684277) (← links)
- Aberrant Expression of Histone Deacetylases 4 in Cognitive Disorders: Molecular Mechanisms and a Potential Target (Q28066685) (← links)
- The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS (Q28244138) (← links)
- NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases (Q35042712) (← links)
- The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice (Q35975087) (← links)
- MutSβ and histone deacetylase complexes promote expansions of trinucleotide repeats in human cells (Q36368825) (← links)
- Acetyltransferases (HATs) as targets for neurological therapeutics (Q37249167) (← links)
- Environmental Enrichment Modified Epigenetic Mechanisms in SAMP8 Mouse Hippocampus by Reducing Oxidative Stress and Inflammaging and Achieving Neuroprotection (Q37345437) (← links)
- Genetic therapy for the nervous system (Q37856565) (← links)
- Epigenetic treatment of neurological disease (Q37962584) (← links)
- Histone-modifying enzymes: regulators of developmental decisions and drivers of human disease. (Q37997085) (← links)
- Targeting Huntington's disease through histone deacetylases (Q38019159) (← links)
- Generating new neurons to circumvent your fears: the role of IGF signaling. (Q38094638) (← links)
- Neuroprotective effects of psychotropic drugs in Huntington's disease (Q38163877) (← links)
- Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors (Q38215303) (← links)
- An acetylation switch controls TDP-43 function and aggregation propensity (Q38301905) (← links)
- Altered expression of 3-betahydroxysterol delta-24-reductase/selective Alzheimer's disease indicator-1 gene in Huntington's disease models. (Q38986023) (← links)
- KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients (Q39375357) (← links)
- HDAC1 regulates fear extinction in mice. (Q47913817) (← links)
- Histone deacetylases (HDACs) in frontotemporal lobar degeneration (Q48075374) (← links)
- Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice (Q100378830) (← links)